Product
IBR854 Cell
1 clinical trial
1 indication
Indication
Solid TumorsClinical trial
A Phase I Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IBR854 Cell Injection in Patients With Unresectable Locally Advanced Or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2024-09-30